# Chattem Inc - Inspection Records

Source: https://www.keypedia.com/companies/chattem-inc/4ca90cd8-88ca-4db8-ad0b-98e339ee0c0a

> Inspection records and compliance data for Chattem Inc in Chattanooga, Tennessee. Access full analysis and detailed observations.

---

## Details

- Name: Chattem Inc
- FEI Number: 1022556
- City: Chattanooga
- State: Tennessee
- Country Name: United States
- Address Line 1: 1715 W 38th St
- Zip Code: 37409

## Related Documents

- [483 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/483/chattem-inc/1124d97e-d527-4a8b-800b-aaadf01694c4) — source: FDA, date: August 22, 2025
- [483 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/483/chattem-inc/15050091-b049-4522-8c16-d1d10d68b3d3) — source: FDA, date: August 22, 2025
- [FDA Inspection 1252094 - Chattem Inc - 2025-08-22](https://www.keypedia.com/records/fda_inspections/chattem-inc/bed12ef7-2891-4d56-9205-bed47d877e3a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2025
- [FDA Inspection 1208887 - Chattem Inc - 2023-06-13](https://www.keypedia.com/records/fda_inspections/chattem-inc/e8888734-30f0-458e-911c-f87aff4fbb74) — classification: No Action Indicated (NAI), source: FDA, date: June 13, 2023
- [483 - Chattem Inc - 2020-03-13](https://www.keypedia.com/records/483/chattem-inc/0647991c-0755-48a7-8806-17e1c3e38c5f) — source: FDA, date: March 13, 2020
- [FDA Inspection 1120793 - Chattem Inc - 2020-03-13](https://www.keypedia.com/records/fda_inspections/chattem-inc/88454c82-7f5f-4b3d-bf67-1e2bb8b4037d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2020
- [FDA Inspection 1017661 - Chattem Inc - 2017-05-04](https://www.keypedia.com/records/fda_inspections/chattem-inc/c6d0c86b-84ea-4481-baa8-ef7e1e1d0184) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 1006624 - Chattem Inc - 2017-03-02](https://www.keypedia.com/records/fda_inspections/chattem-inc/35d1a843-2ebd-42d7-88b2-eb44084a535f) — classification: No Action Indicated (NAI), source: FDA, date: March 2, 2017
- [FDA Inspection 984987 - Chattem Inc - 2016-09-02](https://www.keypedia.com/records/fda_inspections/chattem-inc/a07c4672-0584-4ca5-b13f-3aaf112e4913) — classification: No Action Indicated (NAI), source: FDA, date: September 2, 2016
- [FDA Inspection 870405 - Chattem Inc - 2014-03-14](https://www.keypedia.com/records/fda_inspections/chattem-inc/beb80ae2-3c43-4eec-8e6c-0f5645e7025a) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2014
- [FDA Inspection 840161 - Chattem Inc - 2013-07-12](https://www.keypedia.com/records/fda_inspections/chattem-inc/4d9e406b-e530-4ad8-be44-4b17e113cb85) — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2013
- [FDA Inspection 769263 - Chattem Inc - 2012-02-24](https://www.keypedia.com/records/fda_inspections/chattem-inc/e0166c75-24b0-4238-b231-3faef78d9e30) — classification: No Action Indicated (NAI), source: FDA, date: February 24, 2012
- [FDA Inspection 611696 - Chattem Inc - 2009-09-04](https://www.keypedia.com/records/fda_inspections/chattem-inc/5f67f67c-7083-4030-9154-42166e84e3af) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 4, 2009

## Related Companies

- [Amphastar Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amphastar-pharmaceuticals-inc/e90eb882-5679-4c85-bbc8-f69ca69cc537)
- [Fareva Amboise](https://www.keypedia.com/companies/fareva-amboise/4d8ebbcc-2e13-4584-b144-63aa8191bc92)
- [Liebel-Flarsheim Company LLC](https://www.keypedia.com/companies/liebel-flarsheim-company-llc/ca074473-a6a3-413d-828a-bee4671e7f97)
- [Teva Puerto Rico LLC](https://www.keypedia.com/companies/teva-puerto-rico-llc/1ed3f946-be5e-473a-ae76-ac9abcde2d21)
- [Hikma Farmaceutica, (Portugal) S.A.](https://www.keypedia.com/companies/hikma-farmaceutica-portugal-sa/39ec9f09-5b00-4a12-aa9b-2add04e825e0)
- [AbbVie Ltd](https://www.keypedia.com/companies/abbvie-ltd/b07cdd9b-e7d5-4b8b-b31d-3cc5dd0c3775)
- [Actavis Laboratories UT, Inc.](https://www.keypedia.com/companies/actavis-laboratories-ut-inc/cbe6c043-14c7-4f58-84bf-68647da581f8)
- [Llorens Pharmaceuticals International Division, Inc.](https://www.keypedia.com/companies/llorens-pharmaceuticals-international-division-inc/3bc4594c-275f-4451-9cf8-4e2e9bc14ee4)
- [Corden Pharma S.p.A.](https://www.keypedia.com/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3)
- [PEL Healthcare LLC](https://www.keypedia.com/companies/pel-healthcare-llc/d3d3b397-8bab-4f88-af83-ce4568b55e00)

## Related Officers

- [investigator](https://www.keypedia.com/people/tracy-j-washington/c7e1e89d-3ed9-44af-b6af-a43d084e7fb9)
- [Jeffrey T. Prosterman](https://www.keypedia.com/people/jeffrey-t-prosterman/1343bea3-692d-484e-b29f-c9f8f052f09c)
- [Thuy Tram L. Nguyen](https://www.keypedia.com/people/thuy-tram-l-nguyen/b58f2445-728e-4f79-b7eb-4dfb7e982e25)